(Q42454691)

31 October 2017

title

Stimulatory and inhibitory effects of neuropeptide Y on growth hormone secretion in acromegaly in vivo (English)

1 reference

31 October 2017

Watanobe H

1

1 reference

31 October 2017

Tamura T

series ordinal

2

1 reference

31 October 2017

publication date

1 February 1997

1 reference

31 October 2017

1 reference

31 October 2017

volume

31

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

29-34

1 reference

Neuropeptide Y potentiates the luteinizing hormone (LH) response to LH-releasing hormone in men.

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Neuropeptide Y directly inhibits growth hormone secretion by human pituitary somatotropic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

Expression of Neuropeptide Y Precursor-Immunoreactivity in the Hypothalamic Dopaminergic Tubero-Infundibular System during Lactation in Rodents*

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990016-0

7 January 2021

10.1016/S0143-4179(97)90016-0

Identifiers

DOI

1 reference

31 October 2017

1 reference